MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

MDT

82.53

-3.2%↓

A

122

+0.95%↑

VEEV

167.85

-0.65%↓

HQY

83.95

-2.51%↓

NEOG

9.42

-2.18%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

90.13 -0.11

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

89.96

Max

94.65

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+44.3% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.7B

12B

Ankstesnė atidarymo kaina

90.24

Ankstesnė uždarymo kaina

90.13

Naujienos nuotaikos

By Acuity

50%

50%

159 / 348 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-21 23:27; UTC

Svarbiausios naujienos

BHP Expects Annual Copper Output in Upper Half of Guidance, Finishes China Iron-Ore Negotiations

2026-04-21 23:27; UTC

Karštos akcijos

Stocks to Watch: Sonoco Products, Adobe, Manhattan Associates, Target Hospitality

2026-04-21 23:02; UTC

Uždarbis

Correction to Capital One Financial 1Q Earnings Article

2026-04-21 23:47; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-04-21 23:47; UTC

Rinkos pokalbiai

Nikkei May Decline as Hopes for U.S.-Iran Peace Talks Fade

2026-04-21 23:36; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Market Talk Roundup: Latest on U.S. Politics

2026-04-21 23:36; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Higher After Trump Says U.S. Will Extend Cease-Fire Deadline -- Market Talk

2026-04-21 23:32; UTC

Uždarbis

America Movil 1Q EBITDA MXN94.5B, Up 3.8% on Year >AMX

2026-04-21 23:30; UTC

Uždarbis

America Movil 1Q Rev MXN236.84B, Up 2.1% on Year >AMX

2026-04-21 23:28; UTC

Uždarbis

America Movil 1Q Net MXN23.4B Vs. Net MXN18.7B >AMX

2026-04-21 23:16; UTC

Svarbiausios naujienos

Ampol Entered 2Q With Hedge Book Positioned to Mitigate Volatility

2026-04-21 23:15; UTC

Svarbiausios naujienos

Ampol Entered 2Q With Broad-Based Momentum

2026-04-21 23:15; UTC

Svarbiausios naujienos

Ampol: Suitable Crudes for Lytton Remain Available in Market

2026-04-21 23:14; UTC

Svarbiausios naujienos

Ampol: Crude Supplies Secured Into July

2026-04-21 23:14; UTC

Svarbiausios naujienos

Ampol: Fuel Supplies Secured Until at Least End of May

2026-04-21 23:13; UTC

Svarbiausios naujienos

Ampol: Well Placed for Crude, Product Supply Prior to Iran Conflict

2026-04-21 23:13; UTC

Svarbiausios naujienos

Ampol 1Q Lytton Refinery Production 1.43 Billion Liters

2026-04-21 23:12; UTC

Svarbiausios naujienos

Ampol 1Q Lytton Refiner Margin US$25.45/Bbl

2026-04-21 22:54; UTC

Rinkos pokalbiai

Sell America Trade Could Gain Momentum If Fed Uncertainty Unresolved -- Market Talk

2026-04-21 22:49; UTC

Svarbiausios naujienos

BHP 3Q Average Realized Energy Coal Price $105.61/Ton, Up 10% On-Quarter

2026-04-21 22:49; UTC

Svarbiausios naujienos

BHP 3Q Average Realized Steelmaking Coal Price $226.76/Ton, Up 15% On-Quarter

2026-04-21 22:48; UTC

Svarbiausios naujienos

BHP 3Q Average Realized Iron Ore Price $85.35/Ton, Flat On-Quarter

2026-04-21 22:48; UTC

Įsigijimai, susijungimai, perėmimai

Alliance Portfolio Is Comprised of Five Plants: Batavia, Hillburn, Massena, Shoemaker and Sterling

2026-04-21 22:48; UTC

Svarbiausios naujienos

BHP 3Q Average Realized Copper Price $5.86/Pound, Down 1% On-Quarter

2026-04-21 22:48; UTC

Įsigijimai, susijungimai, perėmimai

PowerTransitions to Buy 323 MW of Power Generation Assets in New York State From Alliance Energy Group

2026-04-21 22:46; UTC

Svarbiausios naujienos

BHP: Has Concluded Iron Ore Sales Contract Negotiations With China Mineral Resources Group

2026-04-21 22:45; UTC

Svarbiausios naujienos

BHP: Pampa Norte Production Down on Ore Complexity, Variation; Declining Grades

2026-04-21 22:45; UTC

Svarbiausios naujienos

BHP: Escondida Concentrator Investment Estimated Between $4.4 Billion-$5.9 Billion

2026-04-21 22:44; UTC

Svarbiausios naujienos

BHP: Escondida Concentrator Project Seen Facing FID in 2027-28

2026-04-21 22:42; UTC

Svarbiausios naujienos

BHP CEO: Centralized Procurement, Low-cost Operations Help Buffer Industry Wide Cost Pressures

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

44.3% į viršų

12 mėnesių prognozė

Vidutinis 131.41 USD  44.3%

Aukščiausias 175 USD

Žemiausias 90 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

19 ratings

18

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

159 / 348 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat